Drug delivery devices are used for administration of drug compounds in effective ways. A central venous catheter is a long, thin, flexible tube used to administer medicines, fluids, nutrients, or blood products and to monitor hemodynamic status of the patients in surgical and critical care settings over a long period of time, usually several weeks or more. GlobalData uses proprietary data and analytics to provide a comprehensive report on the central venous catheters market in Finland. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the central venous catheters market in Finland was B. Braun Melsungen followed by Becton Dickinson and Co, Edwards Lifesciences, ICU Medical, Kimal, Teleflex and Vygon.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Central venous catheters come in different sizes. Antimicrobial, non antimicrobial, and peripherally inserted central venous catheters are included under this category. An antimicrobial central venous catheter is a catheter coated with antimicrobial agents, such as antiseptics or antibiotics. A non antimicrobial central venous catheter does not have any type of antimicrobial coating incorporated into the catheter polymer. A PICC line is a long, thin, soft and flexible catheter (tube) that is inserted through a peripheral vein preferably in the upper arms, and move along until the tip of the tube reaches a large vein above the heart.

The central venous catheters market in Finland can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size central venous catheters in Finland, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.